Magforce logo

Magforce

Stock
Stock
ISIN: DE000A0HGQF5
Ticker: MF6
DE000A0HGQF5
MF6

Price

Price

Frequently asked questions

What is Magforce's market capitalization?

The market capitalization of Magforce is $31.18K. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Magforce?

Magforce's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.368. EPS indicates the company's profitability on a per-share basis.

What is Magforce's revenue over the trailing twelve months?

Over the trailing twelve months, Magforce reported a revenue of $366.72K.

What is the EBITDA for Magforce?

Magforce's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$5.83M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Magforce?

Magforce has a free cash flow of -$5.13M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Magforce's stock?

The 5-year beta for Magforce is 0.52. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Magforce have, and what sector and industry does it belong to?

Magforce employs approximately 69 people. It operates in the Health Care sector, specifically within the Business Services industry.

What is the free float of Magforce's shares?

The free float of Magforce is 29.93M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 
$31.18K

5Y beta

 
0.52

EPS (TTM)

 
-$0.368

Free Float

 
29.93M

Revenue (TTM)

 
$366.72K

EBITDA (TTM)

 
-$5.83M

Free Cashflow (TTM)

 
-$5.13M

Pricing

52W span
$0.0002155$0.0108

Information

Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the tumor tissues and reacting to the presence of a magnetic field; NanoActivator, which are iron oxide nanoparticles for tumors in all areas of the body, and NanoPlan, a software platform that facilitates therapy planning and adjusts proper temperatures for the treatment and and the necessary magnetic field strength. As of December 31, 2011, Nanostart AG held a 49.6%-stake in the Company.

69

Business Services

Health Care

Identifier

ISIN

DE000A0HGQF5

Primary Ticker

MF6
Join the conversation